GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **1251 - 1275** of **4050** in total

« First

‹ Prev

…

47

48

49

50

51

52

53

54

55

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID	Arbitrary Fluorescence Units (AFU) ▲
IgM	Patient 3	-180	mild	G30839DN	83
IgG	Patient 3	11	mild	G54064FW	83
IgM	Patient 3	11	mild	G38488WF	83
IgM	Patient 3	4	mild	G38488WF	83
IgM	Patient 3	4	mild	G94576MN	83
IgG	Patient 4	12	mild	G86156UJ	83
IgM	Patient 2	15	mild	G96557TJ	84
IgM	Patient 2	24	mild	G07483YN	84
IgG	Patient 2	3	mild	G51175PR	84
IgG	Patient 3	-180	mild	G00057MO	84
IgM	Patient 3	-180	mild	G09609EN	84
IgM	Patient 3	-180	mild	G72424VO	84
IgM	Patient 3	11	mild	G00053MO	84
IgM	Patient 3	4	mild	G32611KT	84
IgG	Patient 4	12	mild	G14569AR	84
IgM	Patient 1	22	moderate	G17689EW	85
IgM	Patient 1	22	moderate	G29857RC	85
IgM	Patient 1	6	moderate	G90562PB	85
IgG	Patient 2	15	mild	G43648DB	85
IgM	Patient 2	3	mild	G00068MO	85
IgM	Patient 2	3	mild	G11460AB	85
IgM	Patient 2	3	mild	G82942ZJ	85
IgM	Patient 3	-180	mild	G54064FW	85
IgM	Patient 3	11	mild	G15209MJ	85
IgM	Patient 3	11	mild	G94576MN	85